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Summary
Id genes regulate tumor angiogenesis and loss of Id1 inhibits tumor xenograft growth in mice. Here we evaluate the role
of Id1 in a more clinically relevant tumor model system using a two-step chemical carcinogenesis protocol. Remarkably,
we find that Id1/ mice are more susceptible to skin tumorigenesis compared to their wild-type counterparts. Cutaneous
neoplasms in Id1/ mice show increased proliferation without alterations in tumor angiogenesis; however, Id1/ mice
possess 50% fewer cutaneous  T cells than their wild-type counterparts due to an intrinsic migration defect associated
with loss of expression of the chemokine receptor, CXCR4. We suggest that there are important differences between the
mechanisms of angiogenesis in transplanted and autochthonous tumors and that these findings will have significant
implications for the potential utility of antiangiogenic therapies in cancer.
Introduction in promoting tumor vessel growth, the tumor model system
evaluated in those studies involved either the intradermal injec-
tion of 2  107 xenograft tumor cells into host animals (LydenIn order for tumors to grow beyond a critical size, they must
et al., 1999, 2001) or the use of angiogenic stimuli in matrigeldevelop an associated vasculature. Since the original proposal
plugs. Since much data suggests that tumor angiogenesis isthat targeting a tumor vasculature could be an efficient form of
initiated by an angiogenic switch that shifts the balance of endo-cancer therapy (Folkman, 1971), much data have accumulated
thelial cell growth and migration toward induction of angiogen-to support the critical role of tumor-associated vessels in tumor
esis, (Hanahan and Folkman, 1996), we sought to determinegrowth and progression. Recent studies in genetically altered
whether Id1 expression affects the angiogenic switch in vivomice have supported the notion of tumor angiogenesis being
using a more genetically relevant tumor model system. Here weinitiated by an “angiogenic switch” that tips the balance of angio-
show that skin tumors initiated by classical two-step chemicalgenic factors in favor of endothelial growth and vessel formation
carcinogenesis (Yuspa et al., 1996) do not demonstrate altered(reviewed in Hanahan and Folkman, 1996). Over the past several
angiogenesis in Id1 null animals and propose a model for tumoryears, data have been mounting to support a central role for
angiogenesis that may occur via Id-dependent or Id-indepen-the Id family of helix-loop-helix factors in the process of tumor
dent mechanisms.angiogenesis (Benezra et al., 2001). Remarkably, mice lacking
from 1-3 Id1 and/or Id3 alleles have been demonstrated to resist
growth of tumor explants due to defects in tumor angiogenesis Results
(Lyden et al., 1999). More recently, the angiogenesis inhibitor
thrombospondin-1 was demonstrated to be a target of Id1 tran- Id1 null mice have an increased susceptibility
to skin cancerscriptional repression and was found to be a significant mediator
of the effects of Id1 on tumor angiogenesis in vivo (Volpert et De novo tumor formation and associated angiogenesis were
induced in Id1/ mice using classical two-step chemical carci-al., 2002). While the above studies supported a role for Id genes
S I G N I F I C A N C E
In order for tumors to develop beyond a limited size, they must develop an associated vasculature. The mechanisms underlying
tumor-induced angiogenesis have been a source of great interest since inhibiting tumor vessel growth shows promise as a therapeutic
intervention. The Id proteins regulate tumor angiogenesis in xenograft models and mice lacking Id genes are resistant to transplanted
tumor growth. Here we show that tumor angiogenesis in autochthonous skin tumors does not depend on the expression of Id1. We
further show that loss of Id1 results in loss of expression of chemokine receptors in Id1/ skin-specific  T cells. We suggest that
tumor angiogenesis can occur by Id-dependent and Id-independent mechanisms, which may be a function of CXCR4 receptor
activity, and that these differences are important for the design of antiangiogenic agents for cancer treatment.
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Figure 1. Increased skin tumorigenesis is seen in Id1 null mice
A: Mice treated with DMBA and TPA for 20 weeks.
B: Tumor incidence in Id1/ and Id1/ mice throughout course of treatments.
C: Tumor burden in Id1/ and Id1/ mice throughout course of treatment (mean tumor surface area  SD are shown). D: Histopathology of skin tumors
in Id1/ and Id1/ mice treated with DMBA and TPA. Tumors were either in the form of exophytic papillomas (top) or inverted papillomas (bottom).
E: Ki-67 expression in tumors from Id1/ and Id1/ mice.
F: Keratin-6 (top), -10 (middle), and -14 (bottom) expression in skin tumors from Id1/ and Id1/ mice.
G: Apoptosis as measured by TUNEL staining (top) and DAPI staining (bottom) of skin tumors from Id1/ and Id1/ mice.
nogenesis (Yuspa et al., 1996). Mice were initiated with DMBA (Figure 2A), and tumors were quantitatively assessed for vessel
caliber and density (Figure 2B). Tumor stroma and parenchymaat birth, treated with TPA twice weekly for 20 weeks, and tumors
did not demonstrate significant differences in vessel density orwere evaluated on a weekly basis. Remarkably, we found an
caliber in Id1/ versus Id1/ mice despite an overall increaseincreased incidence of skin tumors and increased tumor burden
in angiogenesis in all tumors versus control normal skin.in Id1/ mice versus wild-type controls (Figures 1A–1C). Histo-
logic evaluation of tumors demonstrated both exophytic and
Id1 null mice lack skin-specific  T cellsinverted squamous papillomas with an increase in cellularity in
Given the paradoxical increase in tumor incidence and progres-Id1/ tumors (Figure 1D). Immunohistochemical evaluations
sion in Id1/ mice, we sought possible mechanisms for differ-
demonstrated increased cellular proliferation in tumors from
ences in tumor growth that might be unrelated to angiogenic
Id1/ mice as measured by Ki-67 expression (Figure 1E) but defects. Id genes have been shown to regulate the development
no significant differences in cellular differentiation patterns of B lymphocytes (Becker-Herman et al., 2002; Sun, 1994; Yo-
(Slaga et al., 1996) as determined by keratin-6, keratin-10, and kota et al., 1999), T lymphocytes (Morrow et al., 1999; Rivera
keratin-14 markers (Figure 1F). Interestingly, tumors from Id1/ et al., 2000), and Langerhans cells (Hacker et al., 2003), and
and Id1/ mice were noted to be Id1 negative by in situ hybrid- associated E proteins have been shown to participate in V(D)J
ization, which differs from the expression seen in human sqau- recombination of the  T cell receptor (Bain et al., 1999); how-
ever, Id1 null mice have been shown to possess normalmous cell carcinomas of the head and neck (Langlands et al.,
lymphoid (CD4, CD8, B220, IgM) and myeloid (Mac-1,2000). They also did not express significant levels of p16/INK4a
GR-1) lineages by fluorescence-activated cell sorter (FACS)(data not shown) as has been seen previously (Mortier et al.,
analysis (Yan et al., 1997). Since  T cells in the skin play an2002), or significant alterations in apoptosis (Figure 1G).
important role in tumor immunosurveillance and mice lacking
T cells have an increased susceptibility to skin tumor develop-
Tumors in Id1 null mice do not show defects ment (Girardi et al., 2001), we evaluated epidermal sheets from
in angiogenesis Id1 null mice for the presence of  T cells and Langerhans
Since Id genes have been demonstrated to affect tumor angio- cells. Id1/ mice were found to possess a 50% reduction in
genesis, tumors from Id1/ and Id1/ mice were evaluated skin-specific  T cells (Figures 3A and 3B) with a normal com-
plement of Langerhans cells (Figure 3C). Since the absolutehistologically for Factor VIII staining of tumor-associated vessels
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Figure 2. Angiogenesis is unaltered in skin tumors from Id1/ and Id1/ mice
A: Factor VIII staining of blood vessels in skin tumors from Id1/ and Id1/ mice (200 magnification).
B: Quantitative analysis of blood vessel density and caliber in Id1/ and Id1/ mice  stardard deviation.
numbers of skin-specific  T cells were decreased in Id1/ involved in the defective homing of V3 T cells to the skin in Id1
null mice or whether the cells themselves possess an intrinsicmice, we evaluated whether this was due to altered thymic
homing defect to the skin.differentiation, altered homing to the skin, or increased destruc-
tion of cells within the skin. Thymuses were obtained from E17.5
Id1 null  T cells have a cell-intrinsic homing defectId1/ and Id1/mouse embryos and analyzed for skin-specific
In order to determine the nature of the homing defect of Id1/ T cells by FACS analysis (V3 TCR). We found a normal
V3 T cells, we performed an in vitro cell migration assay ofcomplement of V3 TCR cells in E17.5 Id1/ thymuses versus
sorted V3 T cells from Id1/ and Id1/ embryonic thymo-wild-type controls, suggesting normal T cell differentiation (Fig-
cytes. Cells were evaluated for migration to the universal T cellure 3D). In addition, evaluation of epidermal  T cells at 1 week
chemokine receptor ligand, CXCL12, at varying concentrations,and 2 weeks of age showed a 50% reduction of  T cells in
and migrated cells were evaluated under fluorescence micros-Id1/ mice versus wild-type controls, similar to that seen in
copy (Figure 4A). We noted a significant difference in V3 T celladult animals (data not shown). We therefore conclude that loss
migration from Id1/ versus Id1/ cells at all concentrations ofof  T cells in the skin of Id1/ mice is due to defects in
CXCL12 tested. We sought in vivo confirmation of this cell-homing of  T cells to the skin and suggest that this reduced
autonomous defect in migration of Id1/ V3 T cells by per-number of skin-specific dendritic cells may account for the in-
forming transplants of Id1/ and Id1/ embryonic thymocytes
creased tumor incidence in Id1/ mice due to associated de-
into RAG/ mice. V3 T cells were evaluated in the skin 6
fects in immune surveillance. weeks post transplantation using fluorescence microscopy (Fig-
Recent studies noted an increased incidence of skin tumors ure 4B). We found that Id1/ V3 T cells were present in the
in mice null for  T cells and that  T cells could kill skin tumor skin of transplanted RAG/ mice on either an SV129 or a
cells by engaging the NGK2d receptor (Girardi et al., 2001). We BALB/C background; however, Id1/ V3 T cells failed to
suggest that even a 50% decrease in  T cells can lead to migrate to the skin of transplanted RAG/ mice to an apprecia-
increased skin tumorigenesis due to a loss of immune surveil- ble extent, thus confirming the cell-autonomous defect in hom-
lance. We further propose that the decrease in epidermal V3 ing of Id1/ V3 T cells to the skin.
T cells is due to a defect in homing of these cells to the skin.
Since we recently identified a series of Id1 target genes that Id1 null  T cells have reduced expression
include thrombospondin-1, extracellular matrix proteins, and of the chemokine receptor CXCR4
integrin receptor subunits (Volpert et al., 2002), we sought to Since we had established a defect in homing of V3 T cells
to the skin in Id1 null cells, we evaluated the expression ofevaluate whether altered expression of such proteins may be
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Figure 3. Id1 null mice show a loss of epidermal  T cells due to defective homing to the skin
A: Immunostaining of V3 T cells in the epidermis of adult Id1/ and Id1/ mice.
B: Quantitative analysis of V3 T cells in the epidermis of adult Id1/ and Id1/ mice.
C: Immunostaining of epidermal Langerhans cells in Id1/ and Id1/ mice.
D: FACS analysis of V3 T cells from E17.5 day embryonic thymuses of Id1/ and Id1/ mice.
E: Quantitative analysis of V3 T cells from E17.5 day embryonic thymuses of Id1/ and Id1/ mice.
chemokine receptors in Id1/ and Id1/ V3 T cells to deter- Discussion
mine whether homing might be altered due to loss of chemokine
Id genes have been implicated in regulating tumor angiogenesisreceptor expression. Id1 expression was evaluated by RT-PCR
since Id null mice show defects in vascularization of tumorin Id1/ and Id1/ V3 T cells to assure that any cell-autono-
xenografts (Lyden et al., 1999, 2001); however, the true contribu-mous defect in homing was due to loss of endogenous Id1
tion of Id genes to the stepwise development of autochthonousexpression. Id1/ V3 T cells demonstrated high-level expres-
tumors has not been evaluated until now. In the above studies,sion of Id1 while Id1/ cells did not express any endogenous
Id1 (Figure 5A). Quantitative RT-PCR evaluation of chemokine we use classical two-step chemical carcinogenesis to define
the role of Id1 in regulating the angiogenic switch in vivo. Re-receptor expression in Id1/ and Id1/ V3 T cells revealed
mild alterations in expression of various chemokine receptors markably, contrary to data seen with xenografts in Id null mice,
skin tumors induced by chemical carcinogens were increased inin Id1/ cells with the exception of the chemokine receptor
CXCR4, which showed 90% loss of expression versus Id1/ onset and progression in Id1 null mice versus wild-type controls.
Histologic evaluation of skin tumors in Id1/ and Id1/ micecells (Figure 5B).
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Figure 4. Id1 null  T cells show an autonomous defect in homing to chemokines
A: In vitro cell migration assay of Id1/ and Id1/ skin-specific  T cells toward varying concentrations (0, 40, 200, 1000 ng/ml) of CXCL12.
B: Embryonic T cell transplants into RAG/ mice. Genotype to the left is that of recipient mouse, genotype to the right is that of donor thymocytes.
failed to demonstrate significant differences in angiogenesis by viewed in Baird et al., 1999) and chemokines have been shown
to mediate T cell homing to the skin (Hwang, 2001), we suggesteither vessel density or vessel caliber despite demonstrated
onset of the angiogenic switch in all tumors versus control nor- that loss of expression of CXCR4 on Id1/ V3 T cells results
in defects in homing to the skin. Interestingly, CXCR4 has beenmal skin. This is in contrast to the defects in angiogenesis noted
in tumor xenografts and matrigel assays in Id1/ mice seen by shown to be the major chemokine receptor expressed on endo-
thelial cells and its expression is induced by VEGF (Salcedous and others (Lyden et al., 2001; Volpert et al., 2002). We
therefore suggest that tumor angiogenesis that occurs through and Oppenheim, 2003). Furthermore, CXCR4 knockout mice
die perinatally due to defects in cardiac development and organ-stepwise genetic events and is associated with the “angiogenic
switch” is not dependent on Id gene expression, whereas angio- associated angiogenesis (Tachibana et al., 1998). In addition,
CXCR4 expression has been demonstrated to be induced ingenesis that occurs in tumor xenografts or matrigel plugs
through the abrupt introduction of angiogenic factors into a invasive breast cancers and melanomas and is associated with
poor prognosis and tumor invasion/metastasis (Muller et al.,severely hypoxic environment is highly dependent on Id gene
expression. We believe that the latter situation may be analo- 2001; Murakami et al., 2002) and has been shown to be down-
regulated by the von Hippel-Lindau tumor suppressor, pVHLgous to what occurs during tumor metastasis (reviewed in Folk-
man, 2002) when highly proliferative tumor cells migrate to a (Staller et al., 2003). Whether Id genes also regulate CXCR4
expression in other cell lineages remains to be determined.novel matrix and must be vascularized (Figure 6).
We found that loss of Id1 resulted in loss of expression of Our data suggest a specific role for Id proteins in regulating
angiogenesis associated with conditions seen in tumor xeno-the chemokine receptor CXCR4 in V3 T cells. Since CXCR4
has been shown to play a critical role in T cell trafficking (re- grafts including severe hypoxia, acidosis, and hypoglycemia,
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Figure 5. Id1/ skin-specific  T cells show loss of expression of the chemokine receptor CXCR4
A: RT-PCR analysis of Id1 expression in Id1/ (/) and Id1/ (/) skin-specific  T cells. M  size marker, P  pos. control, N  neg. control (H20).
B: Quantitative RT-PCR analysis of chemokine receptor expression in Id1/ and Id1/ skin-specific  T cells.
which are often seen in metastatic disease. Since many of the mice were obtained as littermates from heterozygote breedings
and bred into a mixed C57Bl6/Sv129 background for at leastcurrent angiogenesis inhibitors under clinical investigation were
ten generations. For tumor initiation, a single dose of dimethyl-identified by their ability to inhibit angiogenesis and ultimately
benz(a )anthracene (DMBA) (50 	g in 10 	l of acetone) wasgrowth of transplanted tumors (reviewed in Kerbel and Folkman,
applied topically at the backs of mice on the day of birth. For2002) and early trials of these angiogenesis inhibitors in autoch-
tumor promotion, mice were shaved at the backs and treatedthonous tumors in mice (Bergers et al., 1999) and man (Herbst
topically twice per week with 12-O-tetradecanoylphorbol-13-et al., 2002) have been less effective than anticipated, we pro-
acetate (TPA) (5 	g in 50 	l acetone) starting one week afterpose that the utility of such antiangiogenic therapeutics in hu-
DMBA initiation and continuing for 20 weeks. Tumor onset wasman cancers will depend on their ability to inhibit both the
noted in all mice and tumors counted on a weekly basis. Tumorangiogenesis that occurs by the “switch” mechanism support-
size was measured on a weekly basis once tumors reached 1.5ing autochthonous tumor growth and the Id-dependent angio-
mm in diameter. At week 21, all mice were euthanized andgenesis seen in the xenograft model. We therefore await the
tumors were surgically removed for histologic analysis. Thirty
identification of classes of antiangiogenic therapies for cancer
mice from each genotype (Id1/ and Id1/) were used for
that are able to efficiently target both Id-dependent and Id- DMBA  TPA treatment. An additional five mice from each
independent tumor-associated angiogenesis. genotype were used for each set of control treatments (acetone,
DMBA alone, and TPA alone). No tumors resulted from any of
Experimental procedures the control populations.
Chemical carcinogenesis Histologic analysis, immunohistochemistry,
Id1/ mice were established as previously outlined (Yan et and in situ hybridization
al., 1997), bred into a mixed C57Bl6/Sv129 background, and Tumors were fixed in 10% buffered formalin overnight and em-
bedded in paraffin. Thin sections (4–5 	m) were cut and slidesgenotyped as previously noted (Lyden et al., 1999). Wild-type
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Figure 6. Model for Id gene function in tumor angiogenesis
The development of a vasculature in autochthonous tumors with slow onset of increased expression of proangiogenic factors, hypoxia, hypoglycemia,
acidosis (A) is not highly dependent on Id gene expression. Tumors formed in this manner do not demonstrate appreciable alterations in angiogenesis in
Id1 wild-type and Id1 null mice. The development of a vasculature in transplanted tumors that grow with the rapid introduction of high levels of proangiogenic
factors, extreme hypoxia, hypoglycemia, and acidosis (B) is highly dependent on Id gene expression. Mice lacking 1–3 Id1 and/or Id3 alleles fail to maintain
the growth of tumors initiated by this process.
were prepared for H&E and immunohistochemical staining. Tu- CACTCTGTTC
mor sections were deparaffinized in xylene, rehydrated through 3
: CGCCGTTCAGGGTGCTGAGCGGGGCGC.
washing in a graded series of ethanol and water, and micro-
PCR primers for 460 bp DIG riboprobe:waved in 10 mM citrate buffer (pH 6.0) for target retrieval. After
5
: GGATCCTAATACGACTCACTATAGGGAGAGCATGTGTTCCblocking endogenous peroxidase (5 min) and 1 hr blocking with
AGCCGACGATCserum (from secondary antibody host), slides were stained with
3
: CTAAAGTGTTTGTTTAATAACAACAAprimary antibodies. For primary rabbit antibodies (Ki-67, Dia-
nova, cat# dia 550-67, 1:50 diluted; Factor VIII, DAKO, cat# A Two DIG-labeled RNA probes were made by in vitro tran-
0082, 1:200 diluted; keratin 6, clone K6-gen from P. Coulombe scription of the above cDNA templates using DIG RNA labeling
lab, 1:200 diluted; keratin 14, clone 199 from P. Coulombe lab, reagents and T7 RNA polymerase according to the manufactur-
1:400 diluted), experiments were carried out with Dako EnVi- er’s instructions (Boehringer Mannheim). Paraformaldehyde-
sionSystem rabbit kit (Dako, code# K4010) according to man- fixed paraffin-embedded samples were deparaffinized in xylene,
ufacturer’s supplied protocol. For primary mouse antibodies rehydrated in a graded series of ethanol and water, treated with
(keratin 10, Sigma cat# c-7284, 1:100 diluted; p16/ink4a, Santa 1% hydrogen peroxide, permeabilized with 20 ug/ml freshly
Cruz Biotech. cat# sc-1661, 1:25 diluted), slides were incubated prepared Proteinase K (Gibco BRL, cat# 25530-015), and incu-
with primary antibodies for 1 hr and with secondary antibody bated with RNA probes (100 ng/ml) overnight at 65C. After
(biotinylated goat anti-mouse IgG from CalBiochem, cat# washing twice in 2 SSC, slides were incubated at 37C with
OS02B, 1:50 diluted) for an additional hour. Samples were incu- RNase A/T1 cocktail (Ambion cat # 2288) diluted 1:35 in 2
bated with streptavidin-peroxidase for 15 min (from DAKO ARK SSC. Slides were stringently washed twice in 2 SSC, 50%
kit, code# K3954), followed by incubation with DAB Chromo- formamide DI (Sigma, cat# F-7503, deionized by mixed bed
gen (from DAKO ARK kit, code# K3954). Counterstaining was resins) and then once with 0.08 SSC at 60C. Before immuno-
performed with Mayer’s hematoxylin (DAKO, code# S3309) and detection, tissues were blocked with 1% blocking reagent (Boe-
37 mM ammonia. Slides were then coverslipped on an auto- hringer Mannheim) containing 1:20 diluted purified, nonspecific
mated film coverslipper and examined using light microscopy. rabbit immunoglobulins (DAKO). Sections were then incubated
For in situ hybridization, total RNA was made from NIH 3T3 with rabbit HRP-anti-DIG (Dako) diluted 1:100 in blocking buffer
cells using RNeasy Mini Kit (Qiagen, cat# 74104) followed by for 30 min at RT. After washing with 1 TBST, one drop of
cDNA preparation. Two DNA fragments (471 bp and 460 bp) ready-to-use biotinyl-tyramide (DAKO) was added directly to
incorporating T7 promoters into the primers were generated by
slides and incubated in the dark for 15 min at RT. After three
PCR amplification.
washes with 1 TBST, slides were incubated with secondary
streptavidin (from DAKO GenPoint Kit) for 15 min at RT. AfterPCR primers for 471 bp DIG riboprobe:
5
: GGATCCTAATACGACTCACTATAGGGAGAGTTCTCTTCCCA three washes with 1 TBST, slides were developed with DAB
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(DAKO). Cells were counterstained with Mayers Hematoxylin and their skin was analyzed for the presence of V3 T cells
as described.and 37 mM ammonia, coverslipped in permanent mount media
(Dako), and observed using light microscopy.
FACS analysis of  T cells
Thymocytes were harvested from thymus of adult mice (6–8Semiquantitative assessments of angiogenesis
weeks) or embryonic day 17.5 fetuses. Cells were stainedRepresentative histological sections of tumors were stained by
with 1:2000 diluted FITC-conjugated V3 (BD Pharmingen,immunohistochemistry for von Willebrand Factor. Sections were
cat#553229) and 1:800 diluted PE-conjugated CD3 (BD Phar-then scored blinded to group by two experienced persons inde-
mingen, cat# 553063). Stained cells were analyzed in a fluores-pendently (R.M.A., D.L.H.). Scoring was done on a 0 (absent)
cence-activated cell sorter (FACS).to 4 (numerous) scale for number of vessels in the tumor and
on a 0 (absent) to 4 (large) scale for average size of the vessels
Reverse transcription-polymeraseto determine a total score. Conflicting results were reviewed
chain reaction (RT-PCR)until a consensus was reached and the results were then un-
Total RNA was isolated from sorted V3 T cells using theblinded as to genotype.
RNeasy Mini kit (Qiagen) according to manufacturer’s protocol
and cDNA prepared by reverse transcription. Murine Id1 cDNAApoptosis assay
was amplified using the following primers:Formalin-fixed paraffin-embedded tumor sections were treated
in xylene and ethanol, rehydrated, and treated with proteinase Forward primer: 5
-ATGAAGGTCGCCAGTGGC-3

K for target retrieval. Samples were then incubated with TUNEL Reverse primer: 5
-CCTCAGCGACACAAGATGCGATCG-3

(TdT-mediated dUTP nick end labeling) reaction mixture (Roche
Quantitative RT-PCR was performed as previously describedMolecular Biochemicals) for 1 hr at 37C followed by nuclear
(Wiley et al., 2001) using the following primer pairs:staining with DAPI. Slides were then observed using fluores-
cence microscopy. M-CCR10(R432): 5
-TCG TGC GAT GGC CAC AT-3

M-CCR10(F372): 5
-CCA CGC TGG CTT CCT CTT C-3

Epidermal sheet preparation and immunostaining
MCCR5(842F): 5
-GCC ATG CAG GCA ACA GAG A-3
After euthanasia, mice were shaved and remaining hair was
MCCR5(915R); 5
-TCT CCA ACA AAG GCA TAG ATG ACA-3
removed with chemical hair remover (Nair). Dorsal skin was cut
into small pieces and the epidermal side was gently pressed MCCR4(847F); 5
-AAC AGA GCA GTG CGC ATG AT-3

on a glass slide that was prepared with double-sided tape. After MCCR4(913R): 5
-CGT TGT ACG GCG TCC AGA A-3

incubation at 37C in Hank’s BSS containing 20 mM EDTA
MCXCR4(R644): 5
-AGA CCC ACC ATT ATA TGC TGG AA-3
(3 hr) dermis was peeled away gently, leaving the epidermis
MCXCR4(F568); 5
-AGG TAC ATC TGT GAC CGC CTT T-3
attached to the slide. Epidermal sheets were fixed with freshly
prepared 4% paraformaldehyde in PBS for 10 min at RT and MCCR7(F615); 5
-GGA CAC GCT GAG ATG CTC ACT-3

blocked with 1% BSA in PBS for 15 min. Slides were stained with MCCR7(R685): 5
-CCA TCT GGG CCA CTT GGA T-3

1:100 diluted FITC-conjugated V3 antibody (BD Pharmingen,
MCXCR3(R103): 5
-CGC TCT CGT TTT CCC ATA A-3
cat#553229) for 1 hr at RT and observed using fluorescence
MCXCR3(F30): 5
-GCT AGA TGC TCG GAC TTT GC-3
microscopy. For Langerhans cell staining, epidermal sheets
were prepared by cutting and splitting the ears into two parts Results were normalized to expression of glyceraldehyde-
(dorsal and ventral), incubating them in 1% dispase for 1 hr at 3-phosphate dehydrogenase (G3PDH): forward, 5
-ACC CAC
37C, peeling the epidermal sheets from the dermis, and fixing TCC TCC ACC TTT GA-3
; reverse, 5
-CAT ACC AGG AAA TGA
in acetone for 10 min at 4C. Prepared epidermal sheets were GCT TGA CAA -3
) and then multiplied by 107. Results are shown
then blocked with normal goat serum (10%) for 20 min and as means of duplicate samples, which showed 7% variation
incubated overnight with 1:100 diluted primary antibody against between replicated specimens.
Langerhans cells (Rat anti-mouse Ia (eBioscience, cat# 14-5321)
at 4C. After washing, samples were incubated with 1:50 diluted In vitro  T cell migration assay
goat anti-rat IgG-biotin (Cedarlane, cat# CLCC40015) at RT for Embryonic thymocytes were harvested at day E16.5, stained
1 hr followed by another hour of incubation with 1:50 diluted with V3-FITC antibody, and sorted by FACS. Sorted cells were
FITC-conjugated streptavidin (Cedarlane, cat# CLCSA1001) at stained with Calcein (Molecular Probes cat# 3100) at 37C for
RT. Samples were then coverslipped with mount media and 30 min. The chemokine receptor ligand SDF-1/CXCL12 was
observed using fluorescence microscopy. diluted to 40–1000 ng/ml for use in migration assays and placed
in the bottom chamber of a chemotaxis assay plate. Cells were
added to the migration filter (3.2 mm diameter; 8 	m pore size;Embryonic T cell transplants
ChemoTx System, Neuro Probe) and incubated for 3 hr at 37C.E16.5 day pregnant mice (Id1/ and Id1/) were sacrificed
Following migration, cells were visualized using fluorescenceand fetal thymocytes were isolated from the thymic lobes of
microscopy and photographed for analysis.their embryos. 2  106 of above thymocytes (0.5 ml volume)
were then transplanted through eye-vein injection to RAG1/
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